LifeMD Investors Have Opportunity to Lead Securities Fraud Lawsuit

LifeMD investors have an opportunity to lead a securities fraud lawsuit filed by The Rosen Law Firm. The lawsuit alleges that defendants made false and misleading statements and/or failed to disclose material information during the Class Period (May 7, 2025 to August 5, 2025). Investors who purchased LifeMD securities during this time may be entitled to compensation without paying out-of-pocket fees or costs through a contingency fee arrangement. The lead plaintiff deadline is October 27, 2025.

LifeMD, Inc. (LFMD) investors who suffered losses during the Class Period (May 7, 2025 to August 5, 2025) have an opportunity to participate in a securities fraud lawsuit filed by The Rosen Law Firm. The lawsuit alleges that defendants made false and misleading statements and/or failed to disclose material information during this period. Investors who purchased LifeMD securities during this time may be entitled to compensation without paying out-of-pocket fees or costs through a contingency fee arrangement [1].

The lawsuit, Johnston v. LifeMD, Inc., et al., No. 1:25-cv-04761 (E.D.N.Y), focuses on the propriety of LifeMD’s statements on May 6, 2025, when the company reported its Q1 2025 financial results and raised its full year 2025 revenue and adjusted EBITDA guidance. The complaint alleges that LifeMD made false and misleading statements while failing to disclose crucial information to investors. Specifically, it claims that LifeMD materially overstated its competitive position and was reckless in raising its 2025 guidance, because it did not consider rising customer acquisition costs in its RexMD segment and costs related to the sale of drugs intended to treat obesity [3].

Investors who purchased LifeMD securities during the Class Period are encouraged to contact The Rosen Law Firm to learn more about the class action or to request appointment as lead plaintiff. The lead plaintiff deadline is October 27, 2025. To join the LifeMD class action, investors can visit [Rosen Law Firm's website](https://rosenlegal.com/submit-form/?case_id=43810) or contact Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com [2].

References:

[1] https://www.morningstar.com/news/business-wire/20250905627675/deadline-alert-lifemd-inc-lfmd-investors-who-lost-money-urged-to-contact-glancy-prongay-murray-llp-about-securities-fraud-lawsuit
[2] https://www.morningstar.com/news/globe-newswire/9524365/rosen-trusted-investor-counsel-encourages-pubmatic-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-pubm
[3] https://www.morningstar.com/news/globe-newswire/9523552/lifemd-inc-lfmd-hit-with-securities-class-action-after-shares-crash-44-on-q2-2025-earnings-surprise-problems-with-obesity-care-and-rexmd-hagens-berman